MOMA Therapeutics

MOMA Therapeutics

  • Founded: 2020
  • Location: Boston, MA
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Oncology
  • Drug types: ONC
  • Lead product: Undisclosed
  • Product link:
  • Funding: $150M B May 2022; $86M A Apr 2020
  • Investors: Third Rock Ventures

job board

Short description:

Enzymes - Molecular Machines

Drug notes:

Contact us to add description:

Long description:

MOMA Therapeutics is targeting the molecular machines that drive disease with precision medicine. Molecular machines present compelling therapeutic opportunities for disease treatment. They drive both cell growth and survival in cancer, and they are mutated in many genetic disorders. MOMA is singularly focusing on molecular machines and identifying opportunities to drug this class of proteins. To find drugs, MOMA is using their biomechanics engine that incorporates expertise in biochemistry, biophysics, structural biology, computation, chemistry and functional genomics. The platform exploits a key vulnerability to all enzymes in molecular machines: their dependence on well-coordinated conformational changes. MOMA will use this information to advance multiple oncology programs.


MOMA Therapeutics
Sr. Scientist/Principal Scientist, Computational C...
Cambridge, MA|100+ days ago
MOMA Therapeutics
Senior Scientist, Medicinal Chemistry
Cambridge, MA|100+ days ago
MOMA Therapeutics
Director/Senior Director CMC
Cambridge, MA|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy